Filter Results:
(1,243)
Show Results For
- All HBS Web
(1,243)
- People (5)
- News (171)
- Research (927)
- Events (6)
- Multimedia (12)
- Faculty Publications (755)
Show Results For
- All HBS Web
(1,243)
- People (5)
- News (171)
- Research (927)
- Events (6)
- Multimedia (12)
- Faculty Publications (755)
- February 1999
- Teaching Note
Wegmans Food Markets: Diabetes Counseling TN
By: David E. Bell
Teaching Note for (9-599-057). View Details
- 01 Dec 2010
- News
How to Survive Past Start-up
Cenedella tried several other ideas for job-industry companies before he came up with the idea for TheLadders. Michel spent years searching for the right business idea — even helping to start a pharmaceutical industry computer firm —... View Details
- 11 Nov 2015
- Working Paper Summaries
Public R&D Investments and Private-sector Patenting: Evidence from NIH Funding Rules
- September 2003 (Revised January 2004)
- Case
PolyMedica Corporation (B)
By: David F. Hawkins and Jacob Cohen
Supplements the (A) case. View Details
Hawkins, David F., and Jacob Cohen. "PolyMedica Corporation (B)." Harvard Business School Case 104-031, September 2003. (Revised January 2004.)
- January 2017 (Revised March 2017)
- Case
Royal DSM: From Continuous Transformation to Organic Growth
By: William W. George, Carin-Isabel Knoop and Amram Migdal
Royal DSM CEO Feike Sijbesma was pondering the challenges of shifting DSM’s global organization from the constant transformations of the past 100 years to creating organic growth. When Sijbesma took the helm as CEO in 2007, he further pushed and completed the company’s... View Details
Keywords: Organic Growth; Organizational Change; M＆A; Mergers And Acquisitions; Divestment; Business Ventures; Business Divisions; Business Growth and Maturation; Restructuring; Change; Change Management; Transformation; Transition; Engineering; Chemicals; Mining; Ethics; Values and Beliefs; Finance; Capital Markets; Financial Markets; Food; Globalization; Global Strategy; Globalized Firms and Management; Globalized Markets and Industries; Health; Nutrition; History; Leadership; Leadership Development; Leadership Style; Leading Change; Management; Business or Company Management; Growth and Development Strategy; Growth Management; Management Practices and Processes; Management Style; Organizations; Corporate Social Responsibility and Impact; Mission and Purpose; Organizational Change and Adaptation; Organizational Culture; Organizational Design; Ownership; Public Ownership; Performance; Strategy; Adaptation; Consolidation; Corporate Strategy; Value; Value Creation; Pharmaceutical Industry; Pharmaceutical Industry; Pharmaceutical Industry; Pharmaceutical Industry; Pharmaceutical Industry; Europe; Netherlands
George, William W., Carin-Isabel Knoop, and Amram Migdal. "Royal DSM: From Continuous Transformation to Organic Growth." Harvard Business School Case 317-063, January 2017. (Revised March 2017.)
- 25 Feb 2014
- First Look
First Look: February 25
Laboratories' Proposed Merger with King Pharmaceutical Perry Capital owns shares in King and, to facilitate approval of the merger, buys shares in Mylan, whilst hedging out its economic exposure to Mylan's share price using derivatives.... View Details
Keywords: Sean Silverthorne
- 13 Jun 2005
- Research & Ideas
From Turf Wars to Learning Curves: How Hospitals Adopt New Technology
in many cases, perform identical procedures in two or more hospitals during the course of a given week. We have found that this movement has negative effects on the degree to which surgeons are able to leverage their prior experience to improve future performance. We... View Details
- 23 May 2017
- First Look
First Look at New Ideas and Research: May 23, 2017
of one of the top pharmaceutical companies in the world. Vasella, an avowed advocate of diversification, had expanded the scope of the company and structured it into 16 distinct business units ranging from animal health to oncology while... View Details
Keywords: Carmen Nobel
- 01 Jan 2003
- News
Greylock
as Fansteel Metallurgical Corp., Deseret Pharmaceutical Co., New England Nuclear Corp., and Velcro Industries. And by the summer of 1969, it was ready to hire its first associate, Henry McCance, fresh out of three years in defense systems... View Details
- June 2024
- Supplement
Legacy Partners (A)
By: Richard S. Ruback and Royce Yudkoff
Instructors should consider the timing of making videos available to students, as they may reveal key case details.
Stephen Holbrook and Austin Pulsipher (both HBS '19) had been leading Nutrishare since acquiring the company six months earlier in mid-2021.... View Details
Stephen Holbrook and Austin Pulsipher (both HBS '19) had been leading Nutrishare since acquiring the company six months earlier in mid-2021.... View Details
Keywords: Acquisition; Small Business; Cost vs Benefits; Decisions; Corporate Entrepreneurship; Leadership Style; Leading Change; Business or Company Management; Problems and Challenges; Health Care and Treatment; Health Disorders; Medical Specialties; Nutrition; Supply Chain Management; Growth Management; Pharmaceutical Industry; Pharmaceutical Industry; Pharmaceutical Industry; United States; California
Ruback, Richard S., and Royce Yudkoff. "Legacy Partners (A)." Harvard Business School Multimedia/Video Supplement 224-725, June 2024.
- 20 Jan 2015
- First Look
First Look: January 20
School Case 514-084 Vision 2020: Takeda and the Vaccine Business In 2014, Yasuchika Hasegawa was orchestrating the transformation of Takeda from a Japanese pharmaceutical company with a global footprint into a global company with a... View Details
Keywords: Sean Silverthorne
- 03 Sep 2013
- First Look
First Look: September 3
Research Center: Growing a Joint Research Venture in India Bristol Myers Squibb, a multi-national pharmaceutical company, is seeking to globalize its R&D strategy while managing costs. It has formed a joint venture with an Indian... View Details
Keywords: Sean Silverthorne
- 01 Jul 2008
- First Look
First Look: July 1, 2008
establish a proposed alliance with a pharmaceutical firm? Should it create a nutraceuticals business in parallel to its effort to develop anti-aging therapeutics? And, should it in-license a second drug development candidate? Purchase... View Details
Keywords: Martha Lagace
- 01 Mar 2014
- News
My HBS Eureka Moment
uncomfortable with the ethnic background of the proponents, who were proposing to start a pharmaceutical company in Mexico. I could never get comfortable, and missed a huge opportunity. The product was the birth control pill." The lesson... View Details
- 01 Feb 2001
- News
Drilling Down
Exchange. "The role of intellectual capital is more important in this business than any other, except perhaps the pharmaceutical and computer science industries. Oil is a hugely volatile commodity that very few people want to play in, so... View Details
- 13 Jun 2017
- First Look
First Look at New Research and Ideas, June 13
Efforts Pay Off? Dynamic Panel Data Methods Revisited By: Chung, Doug J., Byungyeon Kim, and Byoung Park Abstract—We estimate a sales response model to evaluate the short- and long-term value of pharmaceutical sales representatives'... View Details
Keywords: Sean Silverthorne
- 15 Dec 2014
- Research & Ideas
Deconstructing the Price Tag
expenses incurred. For example, R&D expenditures in the pharmaceutical industry involve more than just the cost of producing one particular drug. Many drugs may have to fail before one succeeds, and that one hit drug ends up... View Details
- 24 Sep 2007
- Research & Ideas
The FDA: What Will the Next 100 Years Bring?
food, medicine, or cosmetics you use. Consumers would end up restricting what they buy to a few trusted brands. In effect, the FDA has made competition possible in consumer products and even in pharmaceuticals (particularly through the... View Details
- 13 Jan 2009
- First Look
First Look: January 13, 2009
and regulation of clinical trials, managerial challenges related to pharmaceutical product testing, and current debates regarding prescription drug safety. Since clinical testing takes between five and seven years, and consumes up to 70... View Details
Keywords: Martha Lagace
- 07 Oct 2014
- First Look
First Look: October 7
(MMRC), and brought together a diverse body of academics, researchers, pharmaceutical and biotech companies, physicians, and patients to combine their efforts around the disease. The MMRF had helped facilitate clinical trials for... View Details
Keywords: Sean Silverthorne